MarkvW said:
Di Luca’s statements are interesting.
As Floyd’s and Tyler’s omissions were a snapshot from the 1999-2004 period Di Luca appears to be giving an insight into what it is today in 2014.
Di Luca has the ability of comparison; between “old cycling” and “new clean era” cycling. He rode during both eras.
His point that doping is no longer talked about in the peloton rings true with the perception of the “new clean era”. Sky and others have leant well from the USPS saga that by openly talking about doping only leaves bread crumbs of evidence.
The second point of interest he made was that doping appears to have shifted to training alone. The risk of doping and racing is now too great. What I believe he meant was exporting the doping products to races is the risk rather than actually testing positive. This shift fits in with the new way of training at Tenerife and racing at sequenced intervals. Also a point to Kerrison’s concept with the Classics team last year of skipping Paris-Nice etc. in preference for a training camp.
The third point in relation to the “90% claim”; what Di Luca said was “Secondo me il 90%” which really means “in my opinion” or “at a guess I would say” – second hand information rather than “I know as fact
“.
What I take from all this fits in with the Sky model. Training camps in far-away places, sequenced tests at races prior to the main objective of the year (TDF etc.), zero tolerance on talking about doping practices, no doping at races or exportation of doping products to races and the non-release of performance data.
Leading on from this point is Walsh (as well as others) are looking for the “USPS model” at Sky. That he won’t find. Doping has shifted and whilst Walsh is looking for “an Emma O'Reilly” or “transfusion kits in the team buses” or “motorman” etc. Sky (and others) have implemented a newer form of doping which limits the risks of detection and being caught at borders etc.
What he’s missing is that doping is defined itself into something new. Something more closely aligned with legal medical products and presented under the guise of performance management and marginal gains.
Di Luca words shouldn’t be dismissed so freely.